News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Psyence Group and Pure Extracts Sign JV Letter of Intent for the Extraction of Psilocybin from Psychedelic Mushrooms and Development of Psilocybin Formulations
Pure Extracts Corp
Nova Mentis Establishes Serotonin Research Centre
Nova Mentis Life Science
Algernon Pharmaceuticals Announces Topline Data From its Phase 2b/3 COVID-19 Trial of Ifenprodil
Algernon Pharmaceuticals
MindMed Announces Filing of Preliminary Base Shelf Prospectus and F-10 with the SEC under MJDS
Mind Medicine (MindMed)
Psyched Wellness Initiates Study on AME-1 Extract for Gut Health
Psyched Wellness
NeonMind CEO Robert Tessarolo to Speak at the Psychedelic, Therapeutics, & Drug Development Conference
NeonMind Biosciences Inc.
MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform
Mind Medicine (MindMed)
Algernon Pharmaceuticals Announces its Addition to the Market's First Psychedelic Stock Index ETF
Algernon Pharmaceuticals
Nova Mentis Announces Promising Research Results
Nova Mentis Life Science
MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board
Mind Medicine (MindMed)
Core One Labs Appoints Dr. Stephen Peach as Head of Patient Research
Core One Labs Inc.
Horizons ETFs Completes Rebalance of World's First Psychedelics ETF
Horizons ETFs Management Inc.
Lobe Sciences
Algernon Pharmaceuticals
Core One Labs Inc.
Creso Pharma Receives Commitments Totaling A$18m
Creso Pharma
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.